BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1153241 Cc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H30FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- LSTQZRJQAIVNIY-WAYWQWQTSA-N 544459 (rac)-(11Z)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 1 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.80 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544459&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591549 469686824 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153242 Cc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H30FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- LSTQZRJQAIVNIY-WAYWQWQTSA-N 544459 (rac)-(11Z)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 1 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544459&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591549 469686824 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153243 Cc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H30FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- LSTQZRJQAIVNIY-WAYWQWQTSA-N 544459 (rac)-(11Z)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 1 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544459&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591549 469686824 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153244 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H32FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) VKPIXYNIBLTMTL-UHFFFAOYSA-N 544460 (rac)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 2::US11286263, Example 3::US11286263, Example 4 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.20 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544460&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591528 469686825 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153245 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H32FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) VKPIXYNIBLTMTL-UHFFFAOYSA-N 544460 (rac)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 2::US11286263, Example 3::US11286263, Example 4 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.30 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544460&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591528 469686825 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153246 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H32FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) VKPIXYNIBLTMTL-UHFFFAOYSA-N 544460 (rac)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 2::US11286263, Example 3::US11286263, Example 4 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544460&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591528 469686825 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153247 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H32FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) VKPIXYNIBLTMTL-UHFFFAOYSA-N 544460 (rac)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 2::US11286263, Example 3::US11286263, Example 4 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544460&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591528 469686825 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153248 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H32FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) VKPIXYNIBLTMTL-UHFFFAOYSA-N 544460 (rac)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 2::US11286263, Example 3::US11286263, Example 4 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 65.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544460&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591528 469686825 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153249 CCc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H32FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- LFYNXMXPUBRIKB-SREVYHEPSA-N 544464 (rac)-(11Z)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 5 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 2.30 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544464&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591541 469686827 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153250 CCc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H32FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- LFYNXMXPUBRIKB-SREVYHEPSA-N 544464 (rac)-(11Z)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 5 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544464&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591541 469686827 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153251 CCc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H32FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- LFYNXMXPUBRIKB-SREVYHEPSA-N 544464 (rac)-(11Z)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 5 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544464&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591541 469686827 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153252 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) UEAZQJUVNIYIGI-UHFFFAOYSA-N 544465 (rac)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 6::US11286263, Example 7::US11286263, Example 8 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.10 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544465&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591482 469686828 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153253 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) UEAZQJUVNIYIGI-UHFFFAOYSA-N 544465 (rac)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 6::US11286263, Example 7::US11286263, Example 8 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.970 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544465&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591482 469686828 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153254 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) UEAZQJUVNIYIGI-UHFFFAOYSA-N 544465 (rac)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 6::US11286263, Example 7::US11286263, Example 8 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544465&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591482 469686828 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153255 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) UEAZQJUVNIYIGI-UHFFFAOYSA-N 544465 (rac)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 6::US11286263, Example 7::US11286263, Example 8 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544465&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591482 469686828 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153256 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) UEAZQJUVNIYIGI-UHFFFAOYSA-N 544465 (rac)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydro-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11286263, Example 6::US11286263, Example 7::US11286263, Example 8 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 26.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544465&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591482 469686828 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153257 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H30FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- QNFLOOBYFATJOG-WAYWQWQTSA-N 544470 (rac)-(Z)-13-fluoro-10,12-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-4,7,9,10-tetrahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 2.40 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544470&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591510 469686831 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153258 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H30FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- QNFLOOBYFATJOG-WAYWQWQTSA-N 544470 (rac)-(Z)-13-fluoro-10,12-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-4,7,9,10-tetrahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 9 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544470&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591510 469686831 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153259 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H30FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- QNFLOOBYFATJOG-WAYWQWQTSA-N 544470 (rac)-(Z)-13-fluoro-10,12-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-4,7,9,10-tetrahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 9 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544470&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591510 469686831 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153260 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H32FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) ZXRSPXBGCWUFRS-UHFFFAOYSA-N 544474 (rac)-13-fluoro-10,12-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,7,9,10-hexahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 10 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.10 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544474&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 156170228 469686833 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153261 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H32FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) ZXRSPXBGCWUFRS-UHFFFAOYSA-N 544474 (rac)-13-fluoro-10,12-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,7,9,10-hexahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 10 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544474&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 156170228 469686833 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153262 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H32FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) ZXRSPXBGCWUFRS-UHFFFAOYSA-N 544474 (rac)-13-fluoro-10,12-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,7,9,10-hexahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 10 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544474&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 156170228 469686833 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153263 CCc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H32FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- AOFDJIUTQZRWFM-SREVYHEPSA-N 544475 (rac)-(Z)-12-ethyl-13-fluoro-10-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,7,9,10-tetrahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 11 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 2.20 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544475&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591496 469686834 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153264 CCc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H32FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- AOFDJIUTQZRWFM-SREVYHEPSA-N 544475 (rac)-(Z)-12-ethyl-13-fluoro-10-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,7,9,10-tetrahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 11 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544475&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591496 469686834 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153265 CCc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H32FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- AOFDJIUTQZRWFM-SREVYHEPSA-N 544475 (rac)-(Z)-12-ethyl-13-fluoro-10-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,7,9,10-tetrahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 11 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544475&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591496 469686834 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153266 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) MWGFNEXKGPQZLE-UHFFFAOYSA-N 544476 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 12::US11286263, Example 13::US11286263, Example 14 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.850 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544476&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591554 469686835 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153267 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) MWGFNEXKGPQZLE-UHFFFAOYSA-N 544476 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 12::US11286263, Example 13::US11286263, Example 14 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.980 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544476&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591554 469686835 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153268 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) MWGFNEXKGPQZLE-UHFFFAOYSA-N 544476 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 12::US11286263, Example 13::US11286263, Example 14 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544476&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591554 469686835 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153269 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) MWGFNEXKGPQZLE-UHFFFAOYSA-N 544476 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 12::US11286263, Example 13::US11286263, Example 14 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544476&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591554 469686835 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153270 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) MWGFNEXKGPQZLE-UHFFFAOYSA-N 544476 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 12::US11286263, Example 13::US11286263, Example 14 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 17.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544476&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591554 469686835 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153271 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.30 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153272 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153273 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153274 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.90 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153275 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153276 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153277 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H31F2N3O4/c1-19-28-26(35-36(19)2)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) YQTBVDPJMZNRCQ-UHFFFAOYSA-N 544479 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 15::US11286263, Example 16::US11286263, Example 17 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 60.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544479&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591477 469686836 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153278 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H36FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) PCJHQKZCIZPRNN-UHFFFAOYSA-N 544482 (rac)-13-fluoro-11,12-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 18 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.60 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544482&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591548 469686837 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153279 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H36FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) PCJHQKZCIZPRNN-UHFFFAOYSA-N 544482 (rac)-13-fluoro-11,12-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 18 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544482&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591548 469686837 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153280 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H36FN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) PCJHQKZCIZPRNN-UHFFFAOYSA-N 544482 (rac)-13-fluoro-11,12-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 18 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544482&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591548 469686837 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153281 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C31H34FN3O4/c1-19-27-25(33-34(19)2)18-38-16-4-3-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-5-10-21(20)26/h6,9,12-14H,3-5,7-8,10-11,15-18H2,1-2H3,(H,36,37) PYAOMBDAWVKXBS-UHFFFAOYSA-N 544483 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 19 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.50 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544483&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591506 469686838 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153282 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C31H34FN3O4/c1-19-27-25(33-34(19)2)18-38-16-4-3-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-5-10-21(20)26/h6,9,12-14H,3-5,7-8,10-11,15-18H2,1-2H3,(H,36,37) PYAOMBDAWVKXBS-UHFFFAOYSA-N 544483 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 19 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544483&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591506 469686838 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153283 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C31H34FN3O4/c1-19-27-25(33-34(19)2)18-38-16-4-3-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-5-10-21(20)26/h6,9,12-14H,3-5,7-8,10-11,15-18H2,1-2H3,(H,36,37) PYAOMBDAWVKXBS-UHFFFAOYSA-N 544483 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 19 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544483&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591506 469686838 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153284 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C30H33ClFN3O4/c1-17-14-20(15-18(2)27(17)31)39-13-7-8-21-22-9-10-23(32)26-25-19(3)34(4)33-24(25)16-38-12-6-5-11-35(28(22)26)29(21)30(36)37/h9-10,14-15H,5-8,11-13,16H2,1-4H3,(H,36,37) NGKIMZZDVOLHFE-UHFFFAOYSA-N 544484 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 20 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.50 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544484&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 156170109 469686839 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153285 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C30H33ClFN3O4/c1-17-14-20(15-18(2)27(17)31)39-13-7-8-21-22-9-10-23(32)26-25-19(3)34(4)33-24(25)16-38-12-6-5-11-35(28(22)26)29(21)30(36)37/h9-10,14-15H,5-8,11-13,16H2,1-4H3,(H,36,37) NGKIMZZDVOLHFE-UHFFFAOYSA-N 544484 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 20 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544484&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 156170109 469686839 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153286 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C30H33ClFN3O4/c1-17-14-20(15-18(2)27(17)31)39-13-7-8-21-22-9-10-23(32)26-25-19(3)34(4)33-24(25)16-38-12-6-5-11-35(28(22)26)29(21)30(36)37/h9-10,14-15H,5-8,11-13,16H2,1-4H3,(H,36,37) NGKIMZZDVOLHFE-UHFFFAOYSA-N 544484 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-11,12-dimethyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 20 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544484&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 156170109 469686839 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153287 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.860 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153288 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.450 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153289 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153290 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153291 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 9.60 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153292 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.580 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153293 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153294 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153295 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) YGMIFQPWWBCCMY-UHFFFAOYSA-N 544485 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 21::US11286263, Example 22::US11286263, Example 23::US11286263, Example 24::US11286263, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 13.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544485&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591494 469686840 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153296 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) OJSSAAYOCAZHRR-UHFFFAOYSA-N 544490 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 26::US11286263, Example 27::US11286263, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.40 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544490&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591516 469686841 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153297 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) OJSSAAYOCAZHRR-UHFFFAOYSA-N 544490 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 26::US11286263, Example 27::US11286263, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.50 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544490&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591516 469686841 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153298 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) OJSSAAYOCAZHRR-UHFFFAOYSA-N 544490 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 26::US11286263, Example 27::US11286263, Example 28 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544490&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591516 469686841 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153299 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) OJSSAAYOCAZHRR-UHFFFAOYSA-N 544490 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 26::US11286263, Example 27::US11286263, Example 28 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544490&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591516 469686841 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153300 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H33F2N3O4/c1-3-27-30-26(36-37(27)2)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) OJSSAAYOCAZHRR-UHFFFAOYSA-N 544490 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 26::US11286263, Example 27::US11286263, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 65.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544490&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591516 469686841 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153301 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H38FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) KWXQEIDOCMCKPC-UHFFFAOYSA-N 544493 (rac)-12-ethyl-13-fluoro-11-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 29::US11286263, Example 30 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.50 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544493&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591513 469686842 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153302 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H38FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) KWXQEIDOCMCKPC-UHFFFAOYSA-N 544493 (rac)-12-ethyl-13-fluoro-11-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 29::US11286263, Example 30 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544493&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591513 469686842 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153303 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H38FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) KWXQEIDOCMCKPC-UHFFFAOYSA-N 544493 (rac)-12-ethyl-13-fluoro-11-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 29::US11286263, Example 30 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544493&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591513 469686842 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153304 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H38FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) KWXQEIDOCMCKPC-UHFFFAOYSA-N 544493 (rac)-12-ethyl-13-fluoro-11-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 29::US11286263, Example 30 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.30 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544493&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591513 469686842 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153305 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H38FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) KWXQEIDOCMCKPC-UHFFFAOYSA-N 544493 (rac)-12-ethyl-13-fluoro-11-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 29::US11286263, Example 30 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544493&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591513 469686842 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153306 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H38FN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) KWXQEIDOCMCKPC-UHFFFAOYSA-N 544493 (rac)-12-ethyl-13-fluoro-11-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 29::US11286263, Example 30 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544493&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591513 469686842 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153307 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C31H35ClFN3O4/c1-5-25-27-24(34-35(25)4)17-39-13-7-6-12-36-29-22(10-11-23(33)26(27)29)21(30(36)31(37)38)9-8-14-40-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,5-9,12-14,17H2,1-4H3,(H,37,38) PPEHYVWZZWCXTO-UHFFFAOYSA-N 544495 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 31 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.80 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544495&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591550 469686843 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153308 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C31H35ClFN3O4/c1-5-25-27-24(34-35(25)4)17-39-13-7-6-12-36-29-22(10-11-23(33)26(27)29)21(30(36)31(37)38)9-8-14-40-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,5-9,12-14,17H2,1-4H3,(H,37,38) PPEHYVWZZWCXTO-UHFFFAOYSA-N 544495 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 31 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544495&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591550 469686843 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153309 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C31H35ClFN3O4/c1-5-25-27-24(34-35(25)4)17-39-13-7-6-12-36-29-22(10-11-23(33)26(27)29)21(30(36)31(37)38)9-8-14-40-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,5-9,12-14,17H2,1-4H3,(H,37,38) PPEHYVWZZWCXTO-UHFFFAOYSA-N 544495 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-11-methyl-4,5,6,7,9,11-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 31 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544495&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591550 469686843 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153310 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H31F2N3O4/c1-19-28-26(36(2)35-19)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NNFVTXYJSONZDH-UHFFFAOYSA-N 544496 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 32 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.10 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544496&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591538 469686844 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153311 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H31F2N3O4/c1-19-28-26(36(2)35-19)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NNFVTXYJSONZDH-UHFFFAOYSA-N 544496 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 32 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544496&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591538 469686844 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153312 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H31F2N3O4/c1-19-28-26(36(2)35-19)18-40-15-4-3-14-37-30-24(12-13-25(34)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(33)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NNFVTXYJSONZDH-UHFFFAOYSA-N 544496 (rac)-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 32 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544496&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591538 469686844 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153313 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H31F2N3O4/c1-19-28-26(36(2)35-19)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) SMQQPFWZHAZLRN-UHFFFAOYSA-N 544497 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 33 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.70 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544497&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591491 469686845 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153314 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H31F2N3O4/c1-19-28-26(36(2)35-19)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) SMQQPFWZHAZLRN-UHFFFAOYSA-N 544497 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 33 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544497&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591491 469686845 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153315 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H31F2N3O4/c1-19-28-26(36(2)35-19)18-40-16-6-5-15-37-30-23(11-12-25(34)29(28)30)22(31(37)32(38)39)10-7-17-41-27-14-13-24(33)20-8-3-4-9-21(20)27/h3-4,8-9,11-14H,5-7,10,15-18H2,1-2H3,(H,38,39) SMQQPFWZHAZLRN-UHFFFAOYSA-N 544497 (rac)-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 33 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544497&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591491 469686845 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153316 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H36FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) YLZNJPDNDBOUOL-UHFFFAOYSA-N 544498 (rac)-13-fluoro-10,12-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 34 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.30 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544498&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591495 469686846 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153317 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H36FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) YLZNJPDNDBOUOL-UHFFFAOYSA-N 544498 (rac)-13-fluoro-10,12-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 34 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544498&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591495 469686846 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153318 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H36FN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) YLZNJPDNDBOUOL-UHFFFAOYSA-N 544498 (rac)-13-fluoro-10,12-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 34 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544498&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591495 469686846 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153319 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C31H34FN3O4/c1-19-27-25(34(2)33-19)18-38-16-4-3-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-5-10-21(20)26/h6,9,12-14H,3-5,7-8,10-11,15-18H2,1-2H3,(H,36,37) JCESVNZJTMLVMU-UHFFFAOYSA-N 544499 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.30 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544499&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591502 469686847 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153320 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C31H34FN3O4/c1-19-27-25(34(2)33-19)18-38-16-4-3-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-5-10-21(20)26/h6,9,12-14H,3-5,7-8,10-11,15-18H2,1-2H3,(H,36,37) JCESVNZJTMLVMU-UHFFFAOYSA-N 544499 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 35 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544499&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591502 469686847 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153321 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C31H34FN3O4/c1-19-27-25(34(2)33-19)18-38-16-4-3-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-5-10-21(20)26/h6,9,12-14H,3-5,7-8,10-11,15-18H2,1-2H3,(H,36,37) JCESVNZJTMLVMU-UHFFFAOYSA-N 544499 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 35 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544499&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591502 469686847 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153322 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c(-c12)c34 InChI=1S/C30H33ClFN3O4/c1-17-14-20(15-18(2)27(17)31)39-13-7-8-21-22-9-10-23(32)26-25-19(3)33-34(4)24(25)16-38-12-6-5-11-35(28(22)26)29(21)30(36)37/h9-10,14-15H,5-8,11-13,16H2,1-4H3,(H,36,37) CMGKPTHVMDFYGM-UHFFFAOYSA-N 544500 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 36 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 2.10 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544500&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591489 469686848 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153323 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c(-c12)c34 InChI=1S/C30H33ClFN3O4/c1-17-14-20(15-18(2)27(17)31)39-13-7-8-21-22-9-10-23(32)26-25-19(3)33-34(4)24(25)16-38-12-6-5-11-35(28(22)26)29(21)30(36)37/h9-10,14-15H,5-8,11-13,16H2,1-4H3,(H,36,37) CMGKPTHVMDFYGM-UHFFFAOYSA-N 544500 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 36 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544500&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591489 469686848 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153324 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c(-c12)c34 InChI=1S/C30H33ClFN3O4/c1-17-14-20(15-18(2)27(17)31)39-13-7-8-21-22-9-10-23(32)26-25-19(3)33-34(4)24(25)16-38-12-6-5-11-35(28(22)26)29(21)30(36)37/h9-10,14-15H,5-8,11-13,16H2,1-4H3,(H,36,37) CMGKPTHVMDFYGM-UHFFFAOYSA-N 544500 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-10,12-dimethyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 36 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544500&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591489 469686848 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153325 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H34FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) YKEWVNLKYIKZMD-UHFFFAOYSA-N 544501 (rac)-12-ethyl-13-fluoro-10-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,7,9,10-hexahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 37 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.20 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544501&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591545 469686849 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153326 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H34FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) YKEWVNLKYIKZMD-UHFFFAOYSA-N 544501 (rac)-12-ethyl-13-fluoro-10-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,7,9,10-hexahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 37 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544501&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591545 469686849 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153327 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H34FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) YKEWVNLKYIKZMD-UHFFFAOYSA-N 544501 (rac)-12-ethyl-13-fluoro-10-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,7,9,10-hexahydro-pyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 37 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544501&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591545 469686849 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153328 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) IBSDWFCAKLNDNF-UHFFFAOYSA-N 544502 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 38::US11286263, Example 39::US11286263, Example 40 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.10 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544502&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591530 469686850 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153329 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) IBSDWFCAKLNDNF-UHFFFAOYSA-N 544502 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 38::US11286263, Example 39::US11286263, Example 40 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.800 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544502&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591530 469686850 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153330 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) IBSDWFCAKLNDNF-UHFFFAOYSA-N 544502 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 38::US11286263, Example 39::US11286263, Example 40 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544502&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591530 469686850 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153331 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) IBSDWFCAKLNDNF-UHFFFAOYSA-N 544502 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 38::US11286263, Example 39::US11286263, Example 40 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544502&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591530 469686850 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153332 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(35)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(34)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) IBSDWFCAKLNDNF-UHFFFAOYSA-N 544502 (rac)-12-ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 38::US11286263, Example 39::US11286263, Example 40 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 40.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544502&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591530 469686850 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153333 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 2.00 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153334 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.70 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153335 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153336 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153337 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 110 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153338 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H38FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) GVABTUFPIIQHMZ-UHFFFAOYSA-N 544508 (rac)-12-ethyl-13-fluoro-10-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.70 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544508&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591479 469686852 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153339 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H38FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) GVABTUFPIIQHMZ-UHFFFAOYSA-N 544508 (rac)-12-ethyl-13-fluoro-10-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 44 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544508&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591479 469686852 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153340 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H38FN3O4/c1-3-26-30-27(36(2)35-26)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h8,11,14-16H,3-7,9-10,12-13,17-20H2,1-2H3,(H,38,39) GVABTUFPIIQHMZ-UHFFFAOYSA-N 544508 (rac)-12-ethyl-13-fluoro-10-methyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 44 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544508&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591479 469686852 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153341 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H36FN3O4/c1-3-25-29-26(35(2)34-25)19-39-17-5-4-16-36-30-23(14-15-24(33)28(29)30)22(31(36)32(37)38)12-8-18-40-27-13-7-10-20-9-6-11-21(20)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) IKFLURFMKRRTAA-UHFFFAOYSA-N 544509 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-13-fluoro-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 45 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.40 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544509&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 156170229 469686853 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153342 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H36FN3O4/c1-3-25-29-26(35(2)34-25)19-39-17-5-4-16-36-30-23(14-15-24(33)28(29)30)22(31(36)32(37)38)12-8-18-40-27-13-7-10-20-9-6-11-21(20)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) IKFLURFMKRRTAA-UHFFFAOYSA-N 544509 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-13-fluoro-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 45 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544509&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 156170229 469686853 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153343 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c(-c12)c34 InChI=1S/C32H36FN3O4/c1-3-25-29-26(35(2)34-25)19-39-17-5-4-16-36-30-23(14-15-24(33)28(29)30)22(31(36)32(37)38)12-8-18-40-27-13-7-10-20-9-6-11-21(20)27/h7,10,13-15H,3-6,8-9,11-12,16-19H2,1-2H3,(H,37,38) IKFLURFMKRRTAA-UHFFFAOYSA-N 544509 (rac)-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-13-fluoro-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 45 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544509&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 156170229 469686853 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153344 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c(-c12)c34 InChI=1S/C31H35ClFN3O4/c1-5-24-27-25(35(4)34-24)17-39-13-7-6-12-36-29-22(10-11-23(33)26(27)29)21(30(36)31(37)38)9-8-14-40-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,5-9,12-14,17H2,1-4H3,(H,37,38) LAVADHQASMMJNR-UHFFFAOYSA-N 544510 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 46 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 2.00 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544510&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591493 469686854 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153345 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c(-c12)c34 InChI=1S/C31H35ClFN3O4/c1-5-24-27-25(35(4)34-24)17-39-13-7-6-12-36-29-22(10-11-23(33)26(27)29)21(30(36)31(37)38)9-8-14-40-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,5-9,12-14,17H2,1-4H3,(H,37,38) LAVADHQASMMJNR-UHFFFAOYSA-N 544510 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 46 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544510&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591493 469686854 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153346 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c(-c12)c34 InChI=1S/C31H35ClFN3O4/c1-5-24-27-25(35(4)34-24)17-39-13-7-6-12-36-29-22(10-11-23(33)26(27)29)21(30(36)31(37)38)9-8-14-40-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,5-9,12-14,17H2,1-4H3,(H,37,38) LAVADHQASMMJNR-UHFFFAOYSA-N 544510 (rac)-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 46 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544510&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591493 469686854 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153347 Cc1c-2c(CNCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H33FN4O3/c1-20-28-26(35-36(20)2)19-34-16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15,34H,5-6,8,12,16-19H2,1-2H3,(H,38,39) QHRUBHVQCBLXPV-UHFFFAOYSA-N 544511 (rac)-4-fluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid trifluoroacetic acid salt::US11286263, Example 47::US11286263, Example 49 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.820 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544511&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591555 469686855 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153348 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.10 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153349 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153350 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c(-c12)c34 InChI=1S/C33H33F2N3O4/c1-3-26-30-27(37(2)36-26)19-41-17-7-6-16-38-31-23(12-13-25(35)29(30)31)22(32(38)33(39)40)11-8-18-42-28-15-14-24(34)20-9-4-5-10-21(20)28/h4-5,9-10,12-15H,3,6-8,11,16-19H2,1-2H3,(H,39,40) JDJKYSNKDLEVMG-UHFFFAOYSA-N 544505 (rac)-12-ethyl-13-fluoro-1-(3-((4-fluoronaphthalen-1-yl)oxy)propyl)-10-methyl-4,5,6,7,9,10-hexahydropyrazolo[4′,3′:9,10][1]oxa[6]azacycloundecino[8,7,6-hi]indole-2-carboxylic acid::US11286263, Example 41::US11286263, Example 42::US11286263, Example 43 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544505&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591524 469686851 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153351 Cc1c-2c(CNCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H33FN4O3/c1-20-28-26(35-36(20)2)19-34-16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15,34H,5-6,8,12,16-19H2,1-2H3,(H,38,39) QHRUBHVQCBLXPV-UHFFFAOYSA-N 544511 (rac)-4-fluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid trifluoroacetic acid salt::US11286263, Example 47::US11286263, Example 49 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 40.0 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544511&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591555 469686855 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153352 Cc1c-2c(C[N+](C)(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H37FN4O3/c1-22-30-28(36-37(22)2)21-39(3,4)19-8-7-18-38-32-26(16-17-27(35)31(30)32)25(33(38)34(40)41)14-10-20-42-29-15-9-12-23-11-5-6-13-24(23)29/h5-6,9,11-13,15-17H,7-8,10,14,18-21H2,1-4H3/p+1 JJYDVUZBTIMLML-UHFFFAOYSA-O 544513 8-carboxy-4-fluoro-2,3,14,14-tetramethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexa-hydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium trifluroacetate::US11286263, Example 50 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.840 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544513&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591552 469686856 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153353 Cc1c-2c(C[N+](C)(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H37FN4O3/c1-22-30-28(36-37(22)2)21-39(3,4)19-8-7-18-38-32-26(16-17-27(35)31(30)32)25(33(38)34(40)41)14-10-20-42-29-15-9-12-23-11-5-6-13-24(23)29/h5-6,9,11-13,15-17H,7-8,10,14,18-21H2,1-4H3/p+1 JJYDVUZBTIMLML-UHFFFAOYSA-O 544513 8-carboxy-4-fluoro-2,3,14,14-tetramethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexa-hydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium trifluroacetate::US11286263, Example 50 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544513&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591552 469686856 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153354 Cc1c-2c(C[N+](C)(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H37FN4O3/c1-22-30-28(36-37(22)2)21-39(3,4)19-8-7-18-38-32-26(16-17-27(35)31(30)32)25(33(38)34(40)41)14-10-20-42-29-15-9-12-23-11-5-6-13-24(23)29/h5-6,9,11-13,15-17H,7-8,10,14,18-21H2,1-4H3/p+1 JJYDVUZBTIMLML-UHFFFAOYSA-O 544513 8-carboxy-4-fluoro-2,3,14,14-tetramethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexa-hydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium trifluroacetate::US11286263, Example 50 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544513&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591552 469686856 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153355 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H39FN4O3/c1-4-27-30-26(35-37(27)3)20-36(2)17-5-6-18-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-9-19-41-28-14-8-11-21-10-7-12-22(21)28/h8,11,14-16H,4-7,9-10,12-13,17-20H2,1-3H3,(H,39,40) LMTGRBLZXQQTBR-UHFFFAOYSA-N 544514 (rac)-7-[3-(2,3-dihydro-1H-inden-4-yloxy)propyl]-3-ethyl-4-fluoro-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 51 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.910 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544514&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591507 469686857 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153356 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H39FN4O3/c1-4-27-30-26(35-37(27)3)20-36(2)17-5-6-18-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-9-19-41-28-14-8-11-21-10-7-12-22(21)28/h8,11,14-16H,4-7,9-10,12-13,17-20H2,1-3H3,(H,39,40) LMTGRBLZXQQTBR-UHFFFAOYSA-N 544514 (rac)-7-[3-(2,3-dihydro-1H-inden-4-yloxy)propyl]-3-ethyl-4-fluoro-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 51 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544514&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591507 469686857 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153357 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H39FN4O3/c1-4-27-30-26(35-37(27)3)20-36(2)17-5-6-18-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-9-19-41-28-14-8-11-21-10-7-12-22(21)28/h8,11,14-16H,4-7,9-10,12-13,17-20H2,1-3H3,(H,39,40) LMTGRBLZXQQTBR-UHFFFAOYSA-N 544514 (rac)-7-[3-(2,3-dihydro-1H-inden-4-yloxy)propyl]-3-ethyl-4-fluoro-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 51 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544514&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591507 469686857 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153358 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H41FN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h9,12,15-17H,4-8,10-11,13-14,18-21H2,1-3H3,(H,40,41) PUUINZYQABKZMG-UHFFFAOYSA-N 544515 (rac)-3-ethyl-4-fluoro-2,14-dimethyl-7-[3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 1.70 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544515&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 142591546 469686858 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153359 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H41FN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h9,12,15-17H,4-8,10-11,13-14,18-21H2,1-3H3,(H,40,41) PUUINZYQABKZMG-UHFFFAOYSA-N 544515 (rac)-3-ethyl-4-fluoro-2,14-dimethyl-7-[3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 52 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544515&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 142591546 469686858 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153360 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H41FN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h9,12,15-17H,4-8,10-11,13-14,18-21H2,1-3H3,(H,40,41) PUUINZYQABKZMG-UHFFFAOYSA-N 544515 (rac)-3-ethyl-4-fluoro-2,14-dimethyl-7-[3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 52 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544515&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 142591546 469686858 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153361 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H36F2N4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(36)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(35)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) JPDSAHHFOVQCCX-UHFFFAOYSA-N 544516 (rac)-3-ethyl-4-fluoro-7-{3-[(6-fluoro-1-naphthyhoxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 53 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.910 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544516&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 155123796 469686859 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153362 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H36F2N4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(36)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(35)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) JPDSAHHFOVQCCX-UHFFFAOYSA-N 544516 (rac)-3-ethyl-4-fluoro-7-{3-[(6-fluoro-1-naphthyhoxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 53 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544516&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 155123796 469686859 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153363 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H36F2N4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(36)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(35)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) JPDSAHHFOVQCCX-UHFFFAOYSA-N 544516 (rac)-3-ethyl-4-fluoro-7-{3-[(6-fluoro-1-naphthyhoxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 53 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544516&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 155123796 469686859 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 1153364 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H37FN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) RYAPMXBEHQNOIT-UHFFFAOYSA-N 544517 (rac)-3-ethyl-4-fluoro-2,14-dimethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 54 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.720 US Patent 10.7270/Q2WW7MWD aid1806417 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3929&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544517&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1&column=ki&startPg=0&Increment=50&submit=Search 155123803 469686860 1 MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR 2KBW,2PQK,3KJ0,3KJ1,3KJ2,3KZ0,3MK8,3PK1,3WIX,3WIY,4HW2,4HW3,4HW4,4WMR,4ZBF,4ZBI,5C3F,5C6H,5FDO,5JSB,5UUM,5W89,5W8F,6MBD,6MBE,6NE5,6O4U,6O6F,6O6G,6OQB,6OQC,6OQD,6OQN,6P3P,6QFI,6QFQ,6QYP,6QZ5,6QZ6,6QZ8,6QZB,6STJ,6U63,6U64,6U65,6U67,6U6F,6UA3,6UAB,6UD2,6UDI,6UDT,6UDU,6UDV,6UDX,6UDY,6VBX,6YBG,6ZIE,7NB4,7NB7,7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 1153365 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H37FN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) RYAPMXBEHQNOIT-UHFFFAOYSA-N 544517 (rac)-3-ethyl-4-fluoro-2,14-dimethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 54 Bcl-2-like protein 1 [1-212] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806418 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1203&target=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544517&enzyme=Bcl-2-like+protein+1+%5B1-212%5D&column=ki&startPg=0&Increment=50&submit=Search 155123803 469686860 1 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1153366 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C34H37FN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) RYAPMXBEHQNOIT-UHFFFAOYSA-N 544517 (rac)-3-ethyl-4-fluoro-2,14-dimethyl-7-[3-(1-naphthyloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11286263, Example 54 Apoptosis regulator Bcl-2 [1-211] Human >20000 US Patent 10.7270/Q2WW7MWD aid1806419 US11286263 Ferrara, SJ; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Furst, L; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Sack, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U 3/29/2022 7/16/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=544517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1204&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=544517&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D&column=ki&startPg=0&Increment=50&submit=Search 155123803 469686860 1 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197